Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

Por Casneuf, Tineke, Axel, Amy E, King, Peter, Alvarez, John D, Werbeck, Jillian L, Verhulst, Tinne, Verstraeten, Karin, Hall, Brett M, Sasser, A Kate
Publicado no Breast Cancer (Dove Med Press) (2016)

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα(2) through IRF9

Por Erb, Holger H H, Langlechner, Regina V, Moser, Patrizia L, Handle, Florian, Casneuf, Tineke, Verstraeten, Karin, Schlick, Bettina, Schäfer, Georg, Hall, Brett, Sasser, Kate, Culig, Zoran, Santer, Frédéric R
Publicado em 2013

Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

Por Lam, Hung-Ming, McMullin, Ryan, Nguyen, Holly M., Coleman, Ilsa, Gormley, Michael, Gulati, Roman, Brown, Lisha G., Holt, Sarah K., Li, Weimin, Ricci, Deborah S., Verstraeten, Karin, Thomas, Shibu, Mostaghel, Elahe A., Nelson, Peter S., Vessella, Robert L., Corey, Eva
Publicado no Clin Cancer Res (2016)